Transduced CLL cells were compared to both mock-transduced cells (PBS) and cells transduced with an irrelevant adenovector, neither of which demonstrated appreciable upregulation of CD95 or CD80 from baseline. This evidence concerns the gene CD80 and B-cell chronic lymphocytic leukemia.